These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

403 related articles for article (PubMed ID: 32789604)

  • 1. Heparin-induced thrombocytopenia in COVID-19 patients with severe acute respiratory distress syndrome requiring extracorporeal membrane oxygenation: two case reports.
    Bidar F; Hékimian G; Martin-Toutain I; Lebreton G; Combes A; Frère C
    J Artif Organs; 2021 Jun; 24(2):277-281. PubMed ID: 32789604
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence and outcomes of patients developing heparin-induced thrombocytopenia during extracorporeal membrane oxygenation.
    Lubnow M; Berger J; Schneckenpointner R; Zeman F; Lunz D; Philipp A; Foltan M; Lehle K; Heimerl S; Hart C; Schmid C; Fisser C; Müller T
    PLoS One; 2022; 17(8):e0272577. PubMed ID: 35939484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Uninterrupted Continuation of VV-ECMO Without Anticoagulation for 44 Days in COVID-19 ARDS: A Precarious Quandary.
    Patel SP; Solomon BJ; Pascotto RD; D'Orazio SE; Navas EV; Cubeddu RJ; Cudemus GA
    J Cardiothorac Vasc Anesth; 2022 Aug; 36(8 Pt B):3193-3196. PubMed ID: 35545457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurologically Devastating Intraparenchymal Hemorrhage in COVID-19 Patients on Extracorporeal Membrane Oxygenation: A Case Series.
    Heman-Ackah SM; Su YS; Spadola M; Petrov D; Chen HI; Schuster J; Lucas T
    Neurosurgery; 2020 Aug; 87(2):E147-E151. PubMed ID: 32424429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heparin-induced thrombocytopenia complicating extracorporeal membrane oxygenation support: Review of the literature and alternative anticoagulants.
    Pollak U
    J Thromb Haemost; 2019 Oct; 17(10):1608-1622. PubMed ID: 31313454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heparin-induced thrombocytopenia complicating extracorporeal membrane oxygenation support in pediatric patients: review of the literature and alternative anticoagulants.
    Pollak U
    Perfusion; 2018 May; 33(1_suppl):7-17. PubMed ID: 29788841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suspected Heparin-Induced Thrombocytopenia in Patients Receiving Extracorporeal Membrane Oxygenation.
    Natt B; Hypes C; Basken R; Malo J; Kazui T; Mosier J
    J Extra Corpor Technol; 2017 Mar; 49(1):54-58. PubMed ID: 28298667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Argatroban for Heparin-Induced Thrombocytopenia during Venovenous Extracorporeal Membrane Oxygenation with Continuous Venovenous Hemofiltration.
    Sin JH; Lopez ND
    J Extra Corpor Technol; 2017 Jun; 49(2):115-120. PubMed ID: 28638161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heparin-induced thrombocytopenia in a pediatric patient receiving extracorporeal support and treated with argatroban.
    Scott LK; Grier LR; Conrad SA
    Pediatr Crit Care Med; 2006 May; 7(3):255-7. PubMed ID: 16474254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heparin-induced thrombocytopenia and extracorporeal membrane oxygenation: a case report and review of the literature.
    Pollak U; Yacobobich J; Tamary H; Dagan O; Manor-Shulman O
    J Extra Corpor Technol; 2011 Mar; 43(1):5-12. PubMed ID: 21449228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of thromboelastography in the management of anticoagulation for veno-venous extracorporeal membrane oxygenation in a coronavirus disease 2019 patient: A case report.
    Nakashima R; Nishihara M; Iyonaga T; Iwasaka S; Yamamoto Y; Shono Y; Maki J; Tokuda K; Akahoshi T; Higo T; Kitazono T; Tsutsui H
    Medicine (Baltimore); 2021 Jun; 100(23):e26313. PubMed ID: 34115042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lung transplantation using argatroban in severe heparin-induced thrombocytopenia during extracorporeal membrane oxygenation: a case series.
    Lee SK; Cho WH; Kim DH; Yeo HJ
    Gen Thorac Cardiovasc Surg; 2020 Dec; 68(12):1565-1568. PubMed ID: 32266702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Argatroban versus heparin in patients without heparin-induced thrombocytopenia during venovenous extracorporeal membrane oxygenation: a propensity-score matched study.
    Fisser C; Winkler M; Malfertheiner MV; Philipp A; Foltan M; Lunz D; Zeman F; Maier LS; Lubnow M; Müller T
    Crit Care; 2021 Apr; 25(1):160. PubMed ID: 33910609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinically suspected heparin-induced thrombocytopenia during extracorporeal membrane oxygenation.
    Glick D; Dzierba AL; Abrams D; Muir J; Eisenberger A; Diuguid D; Abel E; Agerstrand C; Bacchetta M; Brodie D
    J Crit Care; 2015 Dec; 30(6):1190-4. PubMed ID: 26363901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Eleven Years of Venovenous Extracorporeal Membrane Oxygenation for Acute Respiratory Distress Syndrome: From H1N1 to SARS-CoV-2. Experience and Perspectives of a National Referral Center.
    Pieri M; Donatelli V; Calabrò MG; Scandroglio AM; Pappalardo F; Zangrillo A
    J Cardiothorac Vasc Anesth; 2022 Jun; 36(6):1703-1708. PubMed ID: 34686438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcome of acute respiratory distress syndrome requiring extracorporeal membrane oxygenation in Covid-19 or influenza: A single-center registry study.
    Jäckel M; Rilinger J; Lang CN; Zotzmann V; Kaier K; Stachon P; Biever PM; Wengenmayer T; Duerschmied D; Bode C; Staudacher DL; Supady A
    Artif Organs; 2021 Jun; 45(6):593-601. PubMed ID: 33188714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dynamic coagulofibrinolytic responses under long-term VV-ECMO management without anticoagulation in a COVID-19-ARDS patient: A case report.
    Matsumoto H; Kikuchi S; Murata S; Ohshita M; Harima Y; Annen S; Mukai N; Nakabayashi Y; Ogawa S; Okita M; Takeba J; Sato N
    Medicine (Baltimore); 2023 Jan; 102(4):e32817. PubMed ID: 36705388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence and outcome of heparin-induced thrombocytopenia diagnosed under veno-arterial extracorporeal membrane oxygenation: a retrospective nationwide study.
    Kimmoun A; Oulehri W; Sonneville R; Grisot PH; Zogheib E; Amour J; Aissaoui N; Megarbane B; Mongardon N; Renou A; Schmidt M; Besnier E; Delmas C; Dessertaine G; Guidon C; Nesseler N; Labro G; Rozec B; Pierrot M; Helms J; Bougon D; Chardonnal L; Medard A; Ouattara A; Girerd N; Lamiral Z; Borie M; Ajzenberg N; Levy B
    Intensive Care Med; 2018 Sep; 44(9):1460-1469. PubMed ID: 30136139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Argatroban in extracorporeal membrane oxygenation.
    Beiderlinden M; Treschan T; Görlinger K; Peters J
    Artif Organs; 2007 Jun; 31(6):461-5. PubMed ID: 17537058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anticoagulation with argatroban using hemoclot™ targets is safe and effective in CARDS patients receiving venovenous extracorporeal membrane oxygenation: An exploratory bi-centric cohort study.
    Mayerhöfer T; Joannidis M; Peer A; Perschinka F; Fries D; Mair P; Gasteiger L; Bachler M; Kilo J; Herkner H; Schwameis M; Schellongowski P; Nagler B; Kornfehl A; Staudinger T; Buchtele N
    Thromb Res; 2024 Apr; 236():161-166. PubMed ID: 38452448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.